Direct to Consumer Advertising
In: The Elgar Companion to Health Economics
Download full text from publisher
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- Bryn Williams-Jones & Vural Ozdemir, 2008. "Challenges for Corporate Ethics in Marketing Genetic Tests," Journal of Business Ethics, Springer, vol. 77(1), pages 33-44, January.
- Dhaval M. Dave, 2013. "Effects of Pharmaceutical Promotion: A Review and Assessment," NBER Working Papers 18830, National Bureau of Economic Research, Inc.
- W. David Bradford & Andrew N. Kleit, 2012. "Direct to Consumer Advertising for Pharmaceuticals: Research Amid the Controversy," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 31, Edward Elgar Publishing.
- Neha Bairoliya & Pinar Karaca-Mandic & Jeffrey S. McCullough & Amil Petrin, 2017. "Consumer Learning and the Entry of Generic Pharmaceuticals," NBER Working Papers 23662, National Bureau of Economic Research, Inc.
- Rosemary Avery & Donald Kenkel & Dean R. Lillard & Alan Mathios, 2007.
"Private Profits and Public Health: Does Advertising of Smoking Cessation Products Encourage Smokers to Quit?,"
Journal of Political Economy,
University of Chicago Press, vol. 115, pages 447-481.
- Rosemary Avery & Donald Kenkel & Dean R. Lillard & Alan Mathios, 2006. "Private Profits and Public Health: Does Advertising Smoking Cessation Products Encourage Smokers to Quit?," NBER Working Papers 11938, National Bureau of Economic Research, Inc.
- Guy David & Sara Markowitz & Seth Richards-Shubik, 2010.
"The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation,"
American Economic Journal: Economic Policy,
American Economic Association, vol. 2(4), pages 1-25, November.
- Guy David & Sara Markowitz & Seth Richards, 2009. "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation," NBER Working Papers 14634, National Bureau of Economic Research, Inc.
- Cardon & Showalter, 2015. "The effects of direct-to-consumer advertising of pharmaceuticals on adherence," Applied Economics, Taylor & Francis Journals, vol. 47(50), pages 5432-5444, October.
More about this item
KeywordsEconomics and Finance; Social Policy and Sociology;
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:elg:eechap:3572_29. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Darrel McCalla). General contact details of provider: http://www.e-elgar.com .
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.